Company: DVAX
Filing Date: 2025-04-03
Form Type: PREC14A
Source: 0000930413-25-001153
Chunk: 39

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-04-03
Form: PREC14A
Chunk 39
---
 business and affairs.
In addition, such separation helps create an environment that is more conducive to objective evaluation and oversight of management’s
performance, increasing management accountability and improving the ability of our Board to monitor whether management’s
actions are in the best interests of our Company and its stockholders. Our Board leadership structure is reviewed regularly by
our Board.

MEETINGS OF THE BOARD OF DIRECTORS

During 2024, our Board met 12 times. All
Board members attended at least 75% or more of the aggregate number of the meetings of the Board and the committees on which
the member served, that were held during the portion of 2024 for which they were a director or committee member. We have a
policy encouraging our directors’ attendance at our annual meetings. There were four out of nine then-serving directors
in attendance at our 2024 Annual Meeting of Stockholders.

| 27 |

DIRECTOR RECRUITMENT, NOMINATION AND SUCCESSION PLANNING

Our Board and the Nominating and Corporate Governance Committee believe that periodic Board refreshment enhances
the effectiveness of the Board and is an essential element of sound corporate governance. The Nominating and Corporate Governance
Committee monitors the Board composition for size, competence, relevant skills, diversity, tenure, collegiality and independence
as well as individual performance, as appropriate.

The Nominating and Corporate Governance Committee conducts a rigorous process to identify director candidates
and recommend the strongest possible director nominees to the full Board. The Nominating and Corporate Governance Committee conducts
an ongoing refreshment/succession planning process and has retained an executive search firm to assist in identifying prospective
director candidates. During 2024, the Board engaged the services of OCCAM Global LLC (“Occam”) to help identify candidates
for director as part of our ongoing board refreshment program, and Occam identified both Emilio Emini, Ph.D and Lauren Silvernail.
In addition, the Nominating and Corporate Governance Committee considers director candidates recommended or nominated by stockholders.
As part of the annual board assessment process, the Nominating and Corporate Governance Committee considers the skills and experience
that best serve Dynavax and the Board and addresses gaps or succession issues.

When selecting candidates for recommendation to the Board, the Nominating and Corporate Governance Committee
considers the attributes of the candidates and the needs of the Board and strives to review all candidates in the same manner,
regardless of the source of the recommendation. In evaluating director nominees,